logo
ProjectPending

BioVac SA - Multi-Vaccine Project

Sector: Hydrogen • Location: South Africa

Source: International Finance Corporation (IFC)

The proposed investment seeks to support, the Biologicals and Vaccines Institute of Southern Africa ('Biovac' or the 'Company'), a South African biopharmaceutical company based in Cape Town, to expand its suite of products which includes partnering with international vaccine entities through technology transfer agreements for fill and finish manufacturing of vaccines on the continent as well as an

Status
Prospective
Sector
Hydrogen, Biomass, Warehouse, Manufacturing (Industrial), Commercial, Waste Processing and Treatment, Hospital, Government
Location
South Africa
Updated
19 Nov 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about BioVac SA - Multi-Vaccine Project

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “BioVac SA - Multi-Vaccine Project” is an infrastructure initiative in the Hydrogen sector, located in South Africa. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

pending

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

The proposed investment seeks to support, the Biologicals and Vaccines Institute of Southern Africa ('Biovac' or the 'Company'), a South African biopharmaceutical company based in Cape Town, to expand its suite of products which includes partnering with international vaccine entities through technology transfer agreements for fill and finish manufacturing of vaccines on the continent as well as an end to end scale up of an internally developed Oral Cholera Vaccine (OCV). The project will entail developing a new state-of -the-art “green” facility for end-to-end manufacturing to manufacture up to 250 million doses of vaccines per year, thus helping reduce Africa’s over dependence on imported vaccines. It will be comprised of (i) one glass vial fill & finish suite, (ii) one drug substance suite, for the manufacturing of inactivated OCV, and (iii) one blow-fill-seal (plastic line) for Fill & Finish of OCV and other vaccines (the Project).

Original sector

G-FA - Pharmaceuticals and Medicine Manufacturing

Location

Country

South Africa

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Hydrogen, Biomass, Warehouse, Manufacturing (Industrial), Commercial, Waste Processing and Treatment, Hospital, Government

Article published date

2025-12-10

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project